M
Michael R. Loebinger
Researcher at Imperial College London
Publications - 170
Citations - 7417
Michael R. Loebinger is an academic researcher from Imperial College London. The author has contributed to research in topics: Bronchiectasis & Medicine. The author has an hindex of 39, co-authored 139 publications receiving 5393 citations. Previous affiliations of Michael R. Loebinger include University College London & Chelsea and Westminster Hospital NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
European Respiratory Society guidelines for the management of adult bronchiectasis
Eva Polverino,Pieter Goeminne,Melissa J. McDonnell,Melissa J. McDonnell,Stefano Aliberti,Sara E. Marshall,Michael R. Loebinger,Marlene Murris,Rafael Cantón,Antoni Torres,Katerina Dimakou,Anthony De Soyza,Anthony De Soyza,Adam T. Hill,Charles S. Haworth,Montserrat Vendrell,Felix C. Ringshausen,Dragan Subotic,Robert Wilson,Jordi Vilaró,Björn Ställberg,Tobias Welte,Gernot Rohde,Francesco Blasi,Stuart Elborn,Stuart Elborn,Marta Almagro,Alan Timothy,Thomas Ruddy,Thomy Tonia,David Rigau,James D. Chalmers +31 more
TL;DR: The ERS guidelines for the management of adult bronchiectasis describe the appropriate investigation and treatment strategies determined by a systematic review of the literature, using the GRADE approach to define the quality of the evidence and the level of recommendations.
Journal ArticleDOI
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Charles S. Haworth,John Banks,Toby Capstick,Andrew J. Fisher,Thomas Gorsuch,Ian F. Laurenson,Andrew R. Leitch,Michael R. Loebinger,Heather Milburn,Mark Nightingale,Peter Ormerod,Delane Shingadia,David Smith,Nuala Whitehead,Robert Wilson,R. Andres Floto,R. Andres Floto +16 more
TL;DR: Recommendations and recommendations on what samples should be used to detect pulmonary non-tuberculous mycobacterial infection and how to define lung disease attributable to NTM infection are presented.
Journal ArticleDOI
Mesenchymal Stem Cell delivery of TRAIL can eliminate Metastatic Cancer
TL;DR: This is the first study to show a significant reduction in metastatic tumor burden with frequent eradication of metastases using inducible TRAIL-expressing MSCs, which has a wide potential therapeutic role, which includes the treatment of both primary tumors and their metastases.
Journal ArticleDOI
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
Michael R. Loebinger,Athol Wells,David M. Hansell,N Chinyanganya,Anand Devaraj,Mark G. Meister,Robert Wilson +6 more
TL;DR: In patients with moderate to severe bronchiectasis, mortality is associated with a degree of restrictive and obstructive disease, poor gas transfer and chronic pseudomonas infection, which should guide future research into disease progression, and identify those patients needing intensive treatment.
Journal ArticleDOI
British Thoracic Society Guideline for bronchiectasis in adults
Adam T. Hill,Anita L Sullivan,James D. Chalmers,Anthony De Soyza,J. Stuart Elborn,R. Andres Floto,R. Andres Floto,Lizzie Grillo,Kevin Gruffydd-Jones,Alex Harvey,Charles S. Haworth,Edwin Hiscocks,John R. Hurst,Chris Johnson,W Peter Kelleher,W Peter Kelleher,Pallavi Bedi,Karen Payne,Hesham Saleh,Nicholas J. Screaton,Maeve P. Smith,Michael M. Tunney,Deborah Whitters,Robert Wilson,Michael R. Loebinger +24 more
TL;DR: Recommendations for the use of CT imaging protocol for the diagnosis of bronchiectasis and good practice points are given.